We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Approves Subcutaneous Version of Genentech’s Arthritis Drug
FDA Approves Subcutaneous Version of Genentech’s Arthritis Drug
October 25, 2013
The FDA Oct. 21 approved a subcutaneous version of Genentech’s arthritis drug Actemra, giving the drug its sixth U.S. indication in four years.